Drug Profile
Zicronapine
Alternative Names: Lu 31-130; LU 31130Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Lundbeck A/S
- Class Antipsychotics
- Mechanism of Action Neurotransmitter receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 09 Jun 2015 No recent reports on development identified - Phase-II for Schizophrenia in USA, Germany, Hong Kong, Indonesia, Philippines, Spain and Thailand (PO)
- 09 Jun 2015 No recent reports on development identified - Phase-III for Schizophrenia in Czech Republic, Estonia, Finland, France and Poland (PO)
- 11 Apr 2012 Lundbeck completes enrolment in its phase III trial for Schizophrenia in the Czech Republic, Estonia, Finland, France, and Poland (NCT01295372)